---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000733"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2026-01-07T23:59:59+00:00"
generated_at: "2026-05-16T11:20:57.769993+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Processa Pharmaceuticals regains compliance with Nasdaq $1.00 minimum bid price; delisting matter closed

## Summary
- Received Nasdaq notification on January 6, 2026 confirming compliance with Listing Rule 5550(a)(2).
- Company had previously been notified of bid price deficiency; now the deficiency is resolved.
- Nasdaq Capital Market continued listing is no longer at risk from bid price requirement.
- No other material changes; CEO George Ng signed the filing.

## SEC filing metadata
- accession: 0001493152-26-000733
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2026-01-07T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315226000733/0001493152-26-000733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315226000733/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000733
- JSON: https://secwatch.observer/filing/0001493152-26-000733.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000733.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.